Daniel A. Hussar, PhD
FDA approved 55 new drugs in 2023. Twenty-eight (51%) of these new drugs received orphan drug designation because they are used in the treatment of patients with rare diseases. Five new therapeutic agents are considered in this review, the first in a two-part series of articles on new therapeutic agents approved in 2023: bexagliflozin (Brenzavvy-TheracosBio ), sotagliflozin (lnpefa- Lexicon), zavegepant hydrochloride (Zavzpret- Pfizer)/ lecanemab-irmb (Leqembi-Eisai; Biogen), and fezolinetant (Veozah-Astellas).
CPE assessment
This assessment must be taken online; please see “CPE information” in the sidebar on the previous page for further instructions. The online system will present these questions in random order to help reinforce the learning opportunity. There is only one correct answer to each question.
CPE information
To obtain 1 hour of CPE credit for this activity, read the article, successfully complete the online CPE assessment with a 70% or better, and complete the evaluations. The course can be found at: https://learn.pharmacist.com/learn. Pharmacists and pharmacy technicians who successfully complete this activity before April 1, 2027, can receive credit.
You have two opportunities to successfully complete the assessment. This policy is intended to maintain the integrity of the CPE activity. Learners who successfully complete this activity by the expiration date and have their NABP e-Profile ID information on their APhA account will receive CPE credit. Please visit CPE Monitor for your statement of credit.
To earn credit
1. Go to http://apha.us/CPE
2. Log in to your APhA account, or if you do not have an account, register as a new user.
3. Select the course and enroll.
4. Complete the assessment and evaluations.
5. Note: Your APhA My Account must have your NABP e-profile information for your credit to be submitted by APhA to CPE Monitor.
Assistance is available Monday through Friday from 8:30 am to 5:00 pm ET by the APhA Education customer service team by calling 800-237-APhA (2742)
or by e-mailing education@aphanet.org.